Image

This year, Scleroderma News will be offering live, on-site coverage of the 4th Systemic Sclerosis World Conference in Lisbon, Portugal, from February 18-20. Follow everything through the #SSc16 #SclerodermaNews on our Facebook, Twitter, our exclusive board on Pinterest and here: http://bit.ly/1Ts2X9H…

Although women have a greater risk of systemic sclerosis (SSc), they may actually experience a lesser degree of symptoms. An international study based at Cochin Hospital in Paris, extracted data from 9,182 patients with SSc from the European League Against Rheumatism (EULAR) scleroderma trials and research study cohort and discovered…

The 4th Systemic Sclerosis World Congress, organized by the World Scleroderma Foundation (WSF), will run Feb. 18–20 at the Lisbon Congress Center in Lisbon, Portugal, and Scleroderma News Today will be there to cover and report on the proceedings. Learn all about this Scleroderma World Congress here: http://bit.ly/20Q4nQ7…

The 4th Systemic Sclerosis World Congress will take place in Lisbon, Portugal, from 18th to 20th February and Scleroderma News will be covering the whole event. Even though this is a systemic sclerosis (SSc) congress, a lot will be discussed about pulmonary arterial hypertension (PAH), which…

Here are some tips from the organization of the 4th World Scleroderma Congress in Lisbon. Climate Due to the influence of the Atlantic Ocean, Lisbon has a pleasant climate throughout the year. The agreeable temperatures in the summer months are an open invitation for a walk by the river,…

About half of the dentists responding to a survey feared that lack of knowledge might result in harm if they treated scleroderma patients. This concern reduces access to oral health care for scleroderma patients. Dr. David Leader explains what dentists should and would like to know about scleroderma, oral…

Last week’s hot topic on Scleroderma was Potential Scleroderma Gene Therapy Moving Into Preclinical Dosing Study, Fibrocell Reports, written by Daniela Semedo. This article reports the latest advancements in Fibrocell Science Inc.’s pipeline of products focused on autologous cell and gene therapy treatments for several conditions, including…

For the opening keynote of the 2012 edition of the National Patient Education Conference, Jim G. Lemons, Ed.D. speaks on the topic “How to Live with Chronic Illness”, focusing on coping with the disease and improving suffering. More news on systemic sclerosis here: http://bit.ly/20sZaNS…

Tiny pieces of damaged endothelial cells, aptly called “microparticles” due to their size, can be generated in patients with systemic sclerosis (SSc). These cell particulates are created from a variety of processes but are often the result of inflammation or shear stress from blood flow in narrowed arteries. Since pulmonary arterial hypertension (PAH) is…

Scleroderma has been studied for decades through an assessment of skin fibrosis. For this study, lead author and PhD candidate Karen Patterson and Flinders University colleagues took a different approach, looking at the autoantibodies profile of scleroderma patients and their established clinical associations. The team was able to distinguish five…